|
MPHOSPH6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23259999984526E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.87050000000277E-05 |
| Normal-vs-Stage2 |
2.2656999999926E-05 |
| Normal-vs-Stage3 |
4.5031999995615E-07 |
| Normal-vs-Stage4 |
3.86849999811645E-08 |
| Stage1-vs-Stage2 |
1.205160E-01 |
| Stage1-vs-Stage3 |
3.036100E-02 |
| Stage1-vs-Stage4 |
1.437790E-03 |
| Stage2-vs-Stage3 |
9.484400E-01 |
| Stage2-vs-Stage4 |
2.074600E-01 |
| Stage3-vs-Stage4 |
1.762400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.67190000031215E-07 |
| Normal-vs-AfricanAmerican |
1.67437999999409E-05 |
| Normal-vs-Asian |
4.255000E-03 |
| Caucasian-vs-AfricanAmerican |
5.134300E-02 |
| Caucasian-vs-Asian |
3.765000E-01 |
| AfricanAmerican-vs-Asian |
4.750400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29749999528062E-08 |
| Normal-vs-Female |
1.52740000003426E-06 |
| Male-vs-Female |
8.994100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.196700E-04 |
| Normal-vs-Age(41-60Yrs) |
8.66970000235057E-08 |
| Normal-vs-Age(61-80Yrs) |
1.017200002007E-08 |
| Normal-vs-Age(81-100Yrs) |
8.066400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.235610E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.220100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.452640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.742030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.652400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.500000E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.899400E-01 |
| Classical-VS-Follicular |
2.941000E-01 |
| Classical-VS-Other |
7.774000E-01 |
| Classical-VS-Normal |
1.45929999995076E-06 |
| Tall-VS-Follicular |
8.189800E-01 |
| Tall-VS-Other |
8.305000E-01 |
| Tall-VS-Normal |
5.019700E-04 |
| Follicular-VS-Other |
9.221800E-01 |
| Follicular-VS-Normal |
3.58070000000543E-05 |
| Other-VS-Normal |
5.469900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.31409999945842E-07 |
| Normal-vs-N1 |
4.96260000004689E-06 |
| N0-vs-N1 |
5.161600E-01 |
|
|
